[
  {
    "ts": null,
    "headline": "3 Healthcare Stocks with Questionable Fundamentals",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 15.5%. This drop was worse than the S&P 500’s 10% fall.",
    "url": "https://finnhub.io/api/news?id=e7152a2842914e3a599a17de2f41395f9691bca9ee0347b28baaaf9659846c54",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744981338,
      "headline": "3 Healthcare Stocks with Questionable Fundamentals",
      "id": 133964909,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 15.5%. This drop was worse than the S&P 500’s 10% fall.",
      "url": "https://finnhub.io/api/news?id=e7152a2842914e3a599a17de2f41395f9691bca9ee0347b28baaaf9659846c54"
    }
  }
]